Literature DB >> 23696668

The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization.

Mike C L Wu1, Faith H Brennan, Jason P L Lynch, Susanna Mantovani, Simon Phipps, Rick A Wetsel, Marc J Ruitenberg, Stephen M Taylor, Trent M Woodruff.   

Abstract

C3a is a key complement activation fragment, yet its neutrophil-expressed receptor (C3aR) still has no clearly defined role. In this study, we used a neutrophil-dependent mouse model of intestinal ischemia-reperfusion (IR) injury to explore the role of C3aR in acute tissue injuries. C3aR deficiency worsened intestinal injury, which corresponded with increased numbers of tissue-infiltrating neutrophils. Circulating neutrophils were significantly increased in C3aR(-/-) mice after intestinal ischemia, and C3aR(-/-) mice also mobilized more circulating neutrophils after granulocyte colony-stimulating factor infusion compared with WT mice, indicating a specific role for C3aR in constraining neutrophil mobilization in response to intestinal injury. In support of this role, C3aR(-/-) mice reconstituted with WT bone marrow reversed IR pathology back to WT levels. Complement C5a receptor (C5aR) antagonism in C3aR(-/-) mice also rectified the worsened pathology after intestinal IR injury but had no effect on circulating neutrophils, highlighting the opposing roles of C3a and C5a in disease pathogenesis. Finally, we found that using a potent C3a agonist to activate C3aR in vivo reduced neutrophil mobilization and ameliorated intestinal IR pathology in WT, but not C3aR(-/-), mice. This study identifies a role for C3aR in regulating neutrophil mobilization after acute intestinal injury and highlights C3aR agonism as a potential treatment option for acute, neutrophil-driven pathologies.

Entities:  

Keywords:  bone-marrow; intestine; leukocyte; therapeutic

Mesh:

Substances:

Year:  2013        PMID: 23696668      PMCID: PMC3677481          DOI: 10.1073/pnas.1218815110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Designing synthetic superagonists of C3a anaphylatoxin.

Authors:  J A Ember; N L Johansen; T E Hugli
Journal:  Biochemistry       Date:  1991-04-16       Impact factor: 3.162

2.  Degranulation from human eosinophils stimulated with C3a and C5a.

Authors:  S Takafuji; K Tadokoro; K Ito; C A Dahinden
Journal:  Int Arch Allergy Immunol       Date:  1994       Impact factor: 2.749

3.  Diagnostic experiences with the naphthol AS-D chloroacetate esterase reaction.

Authors:  L D Leder
Journal:  Blut       Date:  1970-07

Review 4.  Inhibiting the C5-C5a receptor axis.

Authors:  Trent M Woodruff; Kutty S Nandakumar; Francesco Tedesco
Journal:  Mol Immunol       Date:  2011-05-06       Impact factor: 4.407

5.  In vivo effects of C3a on neutrophils and its contribution to inflammatory lung processes in a guinea-pig model.

Authors:  T Hoffmann; E C Böttger; H P Baum; M Messner; U Hadding; D Bitter-Suermann
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

6.  Complement fragment C3a stimulates Ca2+ influx in neutrophils via a pertussis-toxin-sensitive G protein.

Authors:  J Norgauer; G Dobos; E Kownatzki; C Dahinden; R Burger; R Kupper; P Gierschik
Journal:  Eur J Biochem       Date:  1993-10-01

7.  Acute mesenteric ischemia after cardiopulmonary bypass.

Authors:  M Gennaro; E Ascer; R Matano; I J Jacobowitz; J N Cunningham; P Uceda
Journal:  Am J Surg       Date:  1993-08       Impact factor: 2.565

8.  Ischemia/reperfusion-induced feline intestinal dysfunction: importance of granulocyte recruitment.

Authors:  P Kubes; J Hunter; D N Granger
Journal:  Gastroenterology       Date:  1992-09       Impact factor: 22.682

9.  C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation.

Authors:  P J Daffern; P H Pfeifer; J A Ember; T E Hugli
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

10.  Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells.

Authors:  S G el-Lati; C A Dahinden; M K Church
Journal:  J Invest Dermatol       Date:  1994-05       Impact factor: 8.551

View more
  66 in total

Review 1.  Complement activation in the context of stem cells and tissue repair.

Authors:  Ingrid U Schraufstatter; Sophia K Khaldoyanidi; Richard G DiScipio
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

2.  Differential effects of complement activation products c3a and c5a on cardiovascular function in hypertensive pregnant rats.

Authors:  Kathryn E Lillegard; Alex C Loeks-Johnson; Jonathan W Opacich; Jenna M Peterson; Ashley J Bauer; Barbara J Elmquist; Ronald R Regal; Jeffrey S Gilbert; Jean F Regal
Journal:  J Pharmacol Exp Ther       Date:  2014-08-22       Impact factor: 4.030

Review 3.  From orphan drugs to adopted therapies: Advancing C3-targeted intervention to the clinical stage.

Authors:  Dimitrios C Mastellos; Edimara S Reis; Despina Yancopoulou; George Hajishengallis; Daniel Ricklin; John D Lambris
Journal:  Immunobiology       Date:  2016-06-16       Impact factor: 3.144

Review 4.  Wound repair: role of immune-epithelial interactions.

Authors:  G Leoni; P-A Neumann; R Sumagin; T L Denning; A Nusrat
Journal:  Mucosal Immunol       Date:  2015-07-15       Impact factor: 7.313

5.  Ischemic preconditioning ameliorates intestinal injury induced by ischemia-reperfusion in rats.

Authors:  Yuan-Yuan Ji; Zhi-Dong Wang; Shu-Feng Wang; Bao-Tai Wang; Zheng-An Yang; Xiao-Rong Zhou; Ni-Na Lei; Wei-Na Yue
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

6.  C3a elicits unique migratory responses in immature low-density neutrophils.

Authors:  Brian E Hsu; Joannie Roy; Jack Mouhanna; Roni F Rayes; LeeAnn Ramsay; Sébastien Tabariès; Matthew G Annis; Ian R Watson; Jonathan D Spicer; Santiago Costantino; Peter M Siegel
Journal:  Oncogene       Date:  2020-02-04       Impact factor: 9.867

7.  Radiotherapy: killing with complement.

Authors:  Jean F Regal; Kenneth J Dornfeld; Sherry D Fleming
Journal:  Ann Transl Med       Date:  2016-03

8.  Nrf2 signaling modulates cigarette smoke-induced complement activation in retinal pigmented epithelial cells.

Authors:  Lei Wang; Naoshi Kondo; Marisol Cano; Katayoon Ebrahimi; Takeshi Yoshida; Bradley P Barnett; Shyam Biswal; James T Handa
Journal:  Free Radic Biol Med       Date:  2014-01-17       Impact factor: 7.376

9.  Therapeutic hypothermia modulates complement factor C3a and C5a levels in a rat model of hypoxic ischemic encephalopathy.

Authors:  Tushar A Shah; Jasmine E Nejad; Haree K Pallera; Frank A Lattanzio; Rawad Farhat; Parvathi S Kumar; Pamela S Hair; W Thomas Bass; Neel K Krishna
Journal:  Pediatr Res       Date:  2016-12-21       Impact factor: 3.756

10.  Effects of Well-Controlled HIV Infection on Complement Activation and Function.

Authors:  Alexandria E-B Rossheim; Tina D Cunningham; Pamela S Hair; Tushar Shah; Kenji M Cunnion; Stephanie B Troy
Journal:  J Acquir Immune Defic Syndr       Date:  2016-09-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.